PentaBind
PrivateLast Round
Grant
Jul 1, 2024
Total Funding Raised
$260,000
Company Overview
PentaBind is a biotechnology company that develops precision aptamer therapeutics intended to treat unmet diseases. The company uses artificial intelligence and an integrated wet laboratory to design aptamers that can be used to detect and target almost any molecule of interest, with an initial focus on oncology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PentaBind Comparables
Compare PentaBind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atom Bioworks | 84% | |
| Neoncorte Bio | 79% | |
| Aptamer Group PLC | 75% |
PentaBind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Pre Seed | Jan 11, 2024 | ||||
| Accelerator | Oct 1, 2023 | ||||
| Accelerator | Dec 1, 2022 |
Key People
Founding team and executive leadership
PentaBind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KQ Labs | Accelerator, Pre Seed |
| Hoxton Ventures | Pre Seed |
| Panacea Stars | Accelerator |
| Innovate UK | Grant |
| The Francis Crick Institute | Accelerator |
| LifeArc | Accelerator |
| Next Sequence | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 240% MoM, reaching 1.6K.
- Sep 27, 2024
Grew 67% QoQ, from 6 to 10 employees.
PentaBind Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PentaBind's valuation, stock price, and market status.
Is PentaBind a public or private company?
PentaBind is a private company.
What is the current stock price of PentaBind?
PentaBind is a private company with no public stock price. No recent secondary market data is available.
How much is PentaBind worth (valuation)?
Valuation information for PentaBind is not publicly available.
Can I buy PentaBind stock?
PentaBind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PentaBind's last funding round?
PentaBind's most recent funding round was Grant on July 1, 2024.
Who are the main investors in PentaBind?
Key investors in PentaBind include KQ Labs, Hoxton Ventures, Panacea Stars, Innovate UK, The Francis Crick Institute.
Will PentaBind IPO soon?
No public IPO plans have been announced for PentaBind.
How can I track PentaBind secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PentaBind's secondary market activity and sign up for updates.